Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
7.12
0.00 (0.00%)
Mar 18, 2026, 4:00 PM EDT - Market closed

Climb Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
340191121---
Market Cap Growth
274.77%57.83%----
Enterprise Value
18090.27-29.48000
Last Close Price
7.124.001.80---
PE Ratio
--4.55-1.18---
PB Ratio
2.121.190.57---
P/TBV Ratio
3.011.690.41---
P/FCF Ratio
--3.50-7.78---
P/OCF Ratio
--3.52-7.78---
EV/EBITDA Ratio
--1.330.36---
EV/EBIT Ratio
--1.330.36---
EV/FCF Ratio
--1.661.89---
Debt / Equity Ratio
0.000.000.000.000.000
Debt / EBITDA Ratio
-0.01-0.01-0.01-0.01-0.01-
Debt / FCF Ratio
-0.01-0.01-0.03-0.02-0.01-
Net Debt / Equity Ratio
-0.63-0.63-0.71-0.99-0.96-0.82
Net Debt / EBITDA Ratio
1.481.481.832.642.733.83
Net Debt / FCF Ratio
1.841.849.665.173.293.78
Quick Ratio
14.4714.4730.6137.7020.2722.63
Current Ratio
15.1615.1631.4138.9222.0424.58
Return on Equity (ROE)
-32.15%-32.15%-46.26%-29.72%-30.58%-50.30%
Return on Assets (ROA)
-35.27%-35.27%-50.06%-32.82%-29.29%-36.06%
Return on Invested Capital (ROIC)
-111.81%-111.81%-261.77%-1184.38%-248.27%-220.46%
Return on Capital Employed (ROCE)
-36.40%-36.40%-51.28%-34.05%-30.49%-37.79%
Earnings Yield
-17.60%-22.00%-85.00%---
FCF Yield
-16.04%-28.55%-12.85%---
Buyback Yield / Dilution
-0.03%-0.03%-107.99%---
Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q